Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA: a multicentre cross-sectional study

Postgrad Med J. 2022 Mar;98(e2):e92-e93. doi: 10.1136/postgradmedj-2020-139561.
No abstract available

Keywords: COVID-19; rheumatology.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • Arthritis, Rheumatoid* / epidemiology
  • COVID-19 Drug Treatment*
  • Cross-Sectional Studies
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Prevalence
  • SARS-CoV-2

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine